5175.00
0.76%
BOB Capital Markets Ltd.
Sales/EBITDA/APAT reported 1.3%/2.4% and -3.4% below our estimates. EBITDA margin reported 25bps lower than estimates at 22.2%
Alkem Laboratories Ltd. average weekly volume is high.
More from Alkem Laboratories Ltd.
Recommended